(19)
(11) EP 3 978 924 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
27.09.2023 Bulletin 2023/39

(45) Mention of the grant of the patent:
19.07.2023 Bulletin 2023/29

(21) Application number: 19949161.4

(22) Date of filing: 15.10.2019
(51) International Patent Classification (IPC): 
G01N 33/543(2006.01)
 G01N 33/68(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/6896; G01N 2333/4709; G01N 2800/2821
(86) International application number:
PCT/CN2019/111303
(87) International publication number:
WO 2021/072651 (22.04.2021 Gazette 2021/16)

(54)

TEST STRIP AND METHOD FOR MEASURING URINE A-BETA AMYLOID PROTEIN

TESTSTREIFEN UND VERFAHREN ZUR MESSUNG VON AMYLOID-A-BETA PROTEIN IM HARN

BANDELETTE RÉACTIVE ET PROCÉDÉ DE MESURE DE LA PROTÉINE AMYLOÏDE A-BETA URINAIRE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(43) Date of publication of application:
06.04.2022 Bulletin 2022/14

(73) Proprietor: Hunan Qiankang Technology Co., Ltd.
Hunan 410000 (CN)

(72) Inventors:
  • DAI, Zhengqian
    Changsha, Hunan 410000 (CN)
  • GU, Baijun
    Melbourne, Victoria 3754 (AU)

(74) Representative: Bayramoglu et al. 
Mira Office Kanuni Sultan Süleyman Boulevard 5387 Street Beytepe, floor 12, no:50
06800 Cankaya, Ankara
06800 Cankaya, Ankara (TR)


(56) References cited: : 
WO-A1-2011/057475
WO-A2-02/14351
CN-A- 107 787 326
CN-A- 108 828 238
CN-U- 208 367 017
KR-A- 20190 001 732
KR-A- 20190 001 732
 WO-A1-2018/018138
CN-A- 107 412 782
CN-A- 108 169 492
CN-U- 208 367 017
KR-A- 20180 040 192
KR-A- 20190 001 732
US-A1- 2015 010 534
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).